Application Sponsors
ANDA 211324 | CADILA PHARMS LTD | |
Marketing Status
Application Products
001 | TABLET;ORAL | 60MG | 0 | RALOXIFENE HYDROCHLORIDE | RALOXIFENE HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-08-18 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
CADILA PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 211324
[companyName] => CADILA PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"RALOXIFENE HYDROCHLORIDE","activeIngredients":"RALOXIFENE HYDROCHLORIDE","strength":"60MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"08\/18\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-08-18
)
)